{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T10:46:08Z","timestamp":1795085168934,"version":"4.10.2"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.parkreldis.2021.06.002","type":"journal-article","created":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T03:31:57Z","timestamp":1623123117000},"page":"22-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"special_numbering":"C","title":["Prediabetes, type 2 diabetes mellitus and risk of Parkinson\u2019s disease: A population-based cohort study"],"prefix":"10.1016","volume":"89","author":[{"given":"Almudena","family":"S\u00e1nchez-G\u00f3mez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yesika","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talita","family":"Duarte-Salles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaroslau","family":"Compta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jos\u00e9","family":"Mart\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2021.06.002_bib1","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.pneurobio.2016.10.001","article-title":"Insulin resistance and Parkinson's disease: a new target for disease modification?","volume":"145\u2013146","author":"Athauda","year":"2016","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.parkreldis.2021.06.002_bib2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.parkreldis.2020.08.018","article-title":"Peripheral insulin and amylin levels in Parkinson's disease","volume":"79","author":"S\u00e1nchez-G\u00f3mez","year":"2020","journal-title":"Park. Relat. Disord."},{"issue":"1","key":"10.1016\/j.parkreldis.2021.06.002_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085781","article-title":"Diabetes and risk of Parkinson's disease: an updated meta-analysis of case-control studies","volume":"9","author":"Lu","year":"2014","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.parkreldis.2021.06.002_bib4","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.2337\/dc11-1584","article-title":"Diabetes and risk of Parkinson's disease: a systematic review and meta-analysis","volume":"34","author":"Cereda","year":"2011","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.parkreldis.2021.06.002_bib5","article-title":"Increased risk of Parkinson disease with diabetes mellitus in a population-based study","volume":"96","author":"Yang","year":"2017","journal-title":"Medicine (Baltim.)"},{"issue":"2","key":"10.1016\/j.parkreldis.2021.06.002_bib6","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1212\/WNL.0000000000005771","article-title":"Association between diabetes and subsequent Parkinson disease: a record-linkage cohort study","volume":"91","author":"De Pablo-Fernandez","year":"2018","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.parkreldis.2021.06.002_bib7","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1093\/brain\/awaa262","article-title":"Diabetes medications and risk of Parkinson's disease: a cohort study of patients with diabetes","volume":"143","author":"Brauer","year":"2020","journal-title":"Brain"},{"issue":"10103","key":"10.1016\/j.parkreldis.2021.06.002_bib8","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/S0140-6736(17)31585-4","article-title":"Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Athauda","year":"2017","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.parkreldis.2021.06.002_bib9","first-page":"1","article-title":"Construction and validation of a scoring system for selection of high quality data in a Spanish population primary care database (SIDIAP)","volume":"20","author":"Garc\u00eda-Gil","year":"2012","journal-title":"Inf. Prim. Care"},{"key":"10.1016\/j.parkreldis.2021.06.002_bib10","author":"de Catalunya"},{"key":"10.1016\/j.parkreldis.2021.06.002_bib11","series-title":"Hospital Morbidity Survey: General Methodology","author":"Instituto Nacional de Estad\u00edstica","year":"2019"},{"issue":"12","key":"10.1016\/j.parkreldis.2021.06.002_bib12","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.06.002_bib13","series-title":"Paper Presented at the International Obesity Task Force","article-title":"The global epidemic of obesity. Report of the World Health Organization (WHO) consultation on obesity","author":"Managing","year":"1997"},{"key":"10.1016\/j.parkreldis.2021.06.002_bib14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2147\/CLEP.S129785","article-title":"Missing data and multiple imputation in clinical epidemiological research","volume":"9","author":"Pedersen","year":"2017","journal-title":"Clin. Epidemiol."},{"issue":"5","key":"10.1016\/j.parkreldis.2021.06.002_bib15","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/aje\/kwp425","article-title":"Multiple imputation for missing data: fully conditional specification versus multivariate normal imputation","volume":"171","author":"Lee","year":"2010","journal-title":"Am. J. Epidemiol."},{"issue":"3","key":"10.1016\/j.parkreldis.2021.06.002_bib16","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","article-title":"Proportional hazards tests and diagnostics based on weighted residuals","volume":"81","author":"Grambsch","year":"1994","journal-title":"Biometrika"},{"issue":"10","key":"10.1016\/j.parkreldis.2021.06.002_bib17","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/mds.27802","article-title":"MDS Task Force on the Definition of Parkinson's Disease. Update of the MDS research criteria for prodromal Parkinson's disease","volume":"34","author":"Heinzel","year":"2019","journal-title":"Mov. Disord."},{"issue":"14","key":"10.1016\/j.parkreldis.2021.06.002_bib18","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1212\/WNL.0000000000002414","article-title":"Risk factors for probable REM sleep behavior disorder: a community-based study","volume":"86","author":"Wong","year":"2016","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.parkreldis.2021.06.002_bib19","doi-asserted-by":"crossref","first-page":"9329","DOI":"10.1038\/s41598-020-66319-9","article-title":"Metabolic syndrome does not influence the phenotype of LRRK2 and GBA related Parkinson's disease","volume":"10","author":"Thaler","year":"2020","journal-title":"Sci. Rep."},{"issue":"9833","key":"10.1016\/j.parkreldis.2021.06.002_bib20","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/S0140-6736(12)60283-9","article-title":"Prediabetes: a high-risk state for diabetes development","volume":"379","author":"Tab\u00e1k","year":"2012","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.parkreldis.2021.06.002_bib21","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1080\/03007995.2019.1601455","article-title":"Understanding prediabetes: definition, prevalence, burden and treatment options for an emerging disease","volume":"35","author":"Rett","year":"2019","journal-title":"Curr. Med. Res. Opin."},{"issue":"1","key":"10.1016\/j.parkreldis.2021.06.002_bib22","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S2213-8587(15)00362-9","article-title":"Lifetime risk of developing impaired glucose metabolism and eventual progression from prediabetes to type 2 diabetes: a prospective cohort study","volume":"4","author":"Ligthart","year":"2016","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"5","key":"10.1016\/j.parkreldis.2021.06.002_bib23","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.pcd.2018.07.003","article-title":"Effects of lifestyle changes on adults with prediabetes: a systematic review and meta-analysis","volume":"12","author":"Glechner","year":"2018","journal-title":"Prim. Care Diabetes"},{"key":"10.1016\/j.parkreldis.2021.06.002_bib24","doi-asserted-by":"crossref","DOI":"10.3233\/JPD-202486","article-title":"Diabetes mellitus is associated with a higher relative risk for Parkinson's disease in women than in men","author":"Deischinger","year":"2021","journal-title":"J.\u00a0Parkinsons Dis."},{"issue":"4","key":"10.1016\/j.parkreldis.2021.06.002_bib25","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/jnnp.2003.020982","article-title":"Are men at greater risk for Parkinson's disease than women?","volume":"75","author":"Wooten","year":"2004","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.parkreldis.2021.06.002_bib26","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2337\/dc07-1934","article-title":"Clinical predictors of disease progression and medication initiation in untreated patients with type 2 diabetes and A1C less than 7%","volume":"31","author":"Pani","year":"2008","journal-title":"Diabetes Care"},{"issue":"44","key":"10.1016\/j.parkreldis.2021.06.002_bib27","doi-asserted-by":"crossref","first-page":"12473","DOI":"10.1073\/pnas.1610371113","article-title":"Cross-talk between amyloidogenic proteins in type-2 diabetes and Parkinson's disease","volume":"113","author":"Horvath","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.parkreldis.2021.06.002_bib28","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00401-018-1832-0","article-title":"Interaction of amyloidogenic proteins in pancreatic \u03b2 cells from subjects with synucleinopathies","volume":"135","author":"Martinez-Valbuena","year":"2018","journal-title":"Acta Neuropathol."},{"issue":"2","key":"10.1016\/j.parkreldis.2021.06.002_bib29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10654-009-9405-0","article-title":"The relative importance of modifiable potential risk factors of type 2 diabetes: a meta-analysis of two cohorts","volume":"25","author":"Laaksonen","year":"2010","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.parkreldis.2021.06.002_bib30","first-page":"203930","article-title":"Meta-analysis: overweight, obesity, and Parkinson's disease","volume":"2014","author":"Chen","year":"2014","journal-title":"Internet J. Endocrinol."},{"issue":"6","key":"10.1016\/j.parkreldis.2021.06.002_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002314","article-title":"Estimating the causal influence of body mass index on risk of Parkinson disease: a Mendelian randomisation study","volume":"14","author":"Noyce","year":"2017","journal-title":"PLoS Med."},{"issue":"4","key":"10.1016\/j.parkreldis.2021.06.002_bib32","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1136\/jech.2008.084954","article-title":"Socioeconomic variations in the prevalence and incidence of Parkinson's disease: a population-based analysis","volume":"64","author":"Lix","year":"2010","journal-title":"J.\u00a0Epidemiol. Community Health"},{"issue":"3","key":"10.1016\/j.parkreldis.2021.06.002_bib33","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/mds.20339","article-title":"Disparities in the recording of Parkinson's disease on death certificates","volume":"20","author":"Pressley","year":"2005","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.parkreldis.2021.06.002_bib34","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00420-008-0327-z","article-title":"Socioeconomic and occupational groups and Parkinson's disease: a nationwide study based on hospitalizations in Sweden","volume":"82","author":"Li","year":"2009","journal-title":"Int. Arch. Occup. Environ. Health"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802021002133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802021002133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:21:47Z","timestamp":1761178907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802021002133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":34,"alternative-id":["S1353802021002133"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2021.06.002","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediabetes, type 2 diabetes mellitus and risk of Parkinson\u2019s disease: A population-based cohort study","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2021.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}